solar keratosis
Dermatology · 2008–2008
2decisions
1medicine
0carried consumer input
0individual submissions
Every decision here pre-dates the consumer comments facility, so no input would be recorded either way.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| imiquimod treatment of solar keratosis on the face or scalp in a patient with normal immune function who has multiple clinically evident lesions and requires topical… | Jul 2008 | Recommended | no section in document |
| imiquimod Solar (actinic) keratosis on the face or scalp as field therapy in patients with multiple lesions and normal immune function. | Jul 2008 | Recommended | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 0 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.